TRBV29-1

Across TCGA pan-cancer cohorts, TRBV29-1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated TRBV29-1 data layer compared with 22 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher TRBV29-1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TRBV29-1 expression acts as an unfavorable survival marker.

LUAD, SKCM, and BRCA are the cancer types where TRBV29-1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	0.004	0.751	<.001	18	view →
SKCM	DFS	Median	III,IV	0.204	0.619	.007	11	view →
BRCA	OS	Median	II,III,IV	0.553	0.958	.013	8	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

TRBV29-1–LUAD (OS)

Open the LUAD breakdown →